Pasithea Therapeutics Corporation

06/26/2024 | Press release | Distributed by Public on 06/26/2024 15:01

Submission of Matters to a Vote of Security Holders Form 8 K

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 26, 2024, Pasithea Therapeutics Corp. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). The stockholders of the Company acted upon the following proposals at the Annual Meeting: (1) the election of one Class I director and (2) the ratification of the appointment of Marcum LLP ("Marcum") as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2024.

Of the 1,043,248 shares of common stock of the Company, par value $0.0001 per share (the "Common Stock"), outstanding and entitled to vote at the Annual Meeting, 369,617shares of Common Stock were represented in person or by proxy at the Annual Meeting, thereby constituting a quorum.

The voting results on each of the proposals acted upon at the Annual Meeting are set forth below:

Proposal 1 related to the election of one nominee to serve as a Class I director with a three-year term expiring at the 2027 Annual Meeting of Stockholders or until his or her successor is duly elected and qualified. The following director was approved by a plurality of the votes cast at the Annual Meeting:

FOR WITHHELD BROKER
NON-VOTES
Dr. Emer Leahy 227,198 27,223 115,196

Proposal 2 related to the ratification of the appointment of Marcum as our independent registered public accounting firm for the fiscal year ending December 31, 2024. Proposal 2 was approved by a majority of the votes cast at the Annual Meeting, based upon the following votes:

FOR AGAINST ABSTAIN
333,986 34,177 1,454